Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019.
Eunyong ShinJuhae JinSeo Young ParkYoung Sang YooJi-Hyang LeeJin AnHeung-Woo ParkHyouk-Soo KwonYou-Sook ChoHee-Bom MoonJung-Bok LeeTae Bum KimPublished in: Asia Pacific allergy (2022)
Compared to patients with COVID-19 without chronic obstructive airway disease, patients with these comorbidities are more likely to require oxygen and mechanical ventilators and have a higher mortality rate, which can be considered when classifying and monitoring patients in the era of COVID-19. Therefore, further studies are needed to evaluate the effect of chronic obstructive airway disease, especially ACO, on COVID-19 mortality.
Keyphrases
- chronic obstructive pulmonary disease
- coronavirus disease
- lung function
- sars cov
- cardiovascular events
- end stage renal disease
- ejection fraction
- respiratory syndrome coronavirus
- newly diagnosed
- cystic fibrosis
- air pollution
- risk factors
- patient reported outcomes
- prognostic factors
- drug induced
- coronary artery disease